UNICK FIX-A-FORM AND PRINTERS | BH.IMMUN&BIO | UNICK FIX-A-FORM AND PRINTERS/ BH.IMMUN&BIO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -8.0 | - | View Chart |
P/BV | x | 1.1 | 1.6 | 72.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS BH.IMMUN&BIO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
BH.IMMUN&BIO Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ BH.IMMUN&BIO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 52 | 114.0% | |
Low | Rs | 32 | 21 | 153.7% | |
Sales per share (Unadj.) | Rs | 120.5 | 10.3 | 1,166.7% | |
Earnings per share (Unadj.) | Rs | 4.1 | -3.9 | -105.9% | |
Cash flow per share (Unadj.) | Rs | 11.2 | -3.8 | -294.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 20.4 | 263.9% | |
Shares outstanding (eoy) | m | 5.49 | 43.18 | 12.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 3.5 | 10.7% | |
Avg P/E ratio | x | 11.1 | -9.4 | -118.1% | |
P/CF ratio (eoy) | x | 4.0 | -9.5 | -42.5% | |
Price / Book Value ratio | x | 0.8 | 1.8 | 47.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 1,561 | 15.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 151 | 59.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 446 | 148.3% | |
Other income | Rs m | 5 | 11 | 48.2% | |
Total revenues | Rs m | 667 | 457 | 146.0% | |
Gross profit | Rs m | 88 | -161 | -54.6% | |
Depreciation | Rs m | 39 | 2 | 1,958.5% | |
Interest | Rs m | 24 | 71 | 33.7% | |
Profit before tax | Rs m | 30 | -223 | -13.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | -56 | -13.3% | |
Profit after tax | Rs m | 22 | -166 | -13.5% | |
Gross profit margin | % | 13.3 | -36.0 | -36.8% | |
Effective tax rate | % | 25.0 | 25.3 | 98.9% | |
Net profit margin | % | 3.4 | -37.3 | -9.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 358 | 84.1% | |
Current liabilities | Rs m | 287 | 940 | 30.5% | |
Net working cap to sales | % | 2.1 | -130.6 | -1.6% | |
Current ratio | x | 1.0 | 0.4 | 275.5% | |
Inventory Days | Days | 4 | 85 | 4.5% | |
Debtors Days | Days | 72,349,839 | 1,135 | 6,372,444.1% | |
Net fixed assets | Rs m | 402 | 1,262 | 31.8% | |
Share capital | Rs m | 55 | 432 | 12.7% | |
"Free" reserves | Rs m | 241 | 450 | 53.5% | |
Net worth | Rs m | 296 | 882 | 33.5% | |
Long term debt | Rs m | 89 | 0 | - | |
Total assets | Rs m | 705 | 1,620 | 43.5% | |
Interest coverage | x | 2.3 | -2.2 | -104.7% | |
Debt to equity ratio | x | 0.3 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.3 | 340.6% | |
Return on assets | % | 6.6 | -5.9 | -110.8% | |
Return on equity | % | 7.6 | -18.9 | -40.2% | |
Return on capital | % | 14.0 | -17.2 | -81.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 14.5 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 65 | 0.0% | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 65 | 0.0% | |
Net fx | Rs m | 0 | -65 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 109 | 40.1% | |
From Investments | Rs m | -27 | 5 | -584.8% | |
From Financial Activity | Rs m | -16 | -147 | 11.1% | |
Net Cashflow | Rs m | 0 | -34 | -1.0% |
Indian Promoters | % | 71.6 | 59.3 | 120.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 40.8 | 69.8% | |
Shareholders | 1,622 | 35,313 | 4.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | BH.IMMUN&BIO | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | -2.69% | -0.26% |
1-Month | 21.23% | 6.17% | -0.74% |
1-Year | 56.84% | 31.70% | 29.95% |
3-Year CAGR | 31.01% | -9.09% | 10.57% |
5-Year CAGR | 20.58% | 32.05% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the BH.IMMUN&BIO share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of BH.IMMUN&BIO the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of BH.IMMUN&BIO.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
BH.IMMUN&BIO paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of BH.IMMUN&BIO.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.